http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4649142-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46 |
| filingDate | 1985-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1987-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb453a5b84df81f5f81b2d897200e3ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a36a0c51bc8e2a22e87ea7e889a154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19879c77ebeed9af3dbbcfba0bc081b2 |
| publicationDate | 1987-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4649142-A |
| titleOfInvention | 3,4-dihydro-1,3-disubstituted-6-(substituted phenylimino)-2(1H)-pyrimidinone useful as cardiotonic agent and anti-allergic agent |
| abstract | The invention relates to novel pyrimidinone compounds of anti-allergic and cardiotonic activity of the formula: <IMAGE> wherein R1 and R2 are each lower alkyl, lower alkoxycarbonyl(lower)alkyl, carboxy(lower)alkyl or di(lower)alkylamino(lower)alkyl, R3 is hydroxy, lower alkoxy, halo(lower)alkoxy, lower alkylthio, lower alkanesulfinyl, lower alkanesulfonyl, nitro, amino or di(lower)alkanesulfonylamino, R4 is hydroxy, lower alkoxy, halo(lower)alkoxy, lower alkoxycarbonyl(lower)alkoxy or carboxy(lower)alkoxy, or R3 and R4 are taken together to form lower alkylenedioxy or lower alkylidenedioxy, R5 is phenyl substituted with 1 to 4 substituents selected from the group consisting of lower alkyl and sulfamyl, R10 is hydrogen or sulfamyl, provided that when both of R1 and R2 are lower alkyl and R3 and R4 are lower alkoxy, then R10 is sulfamoyl, and that when R3 is hydroxy, then R4 is hydroxy, and pharmaceutically acceptable salts thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003153584-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7501429-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009005674-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009005674-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006014752-A1 |
| priorityDate | 1984-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 471.